8GCY

Co-crystal structure of CBL-B in complex with N-Aryl isoindolin-1-one inhibitor

Summary for 8GCY

Entry DOI	10.2210/pdb8gcy/pdb
Descriptor	E3 ubiquitin-protein ligase CBL-B, ZINC ION, 2-{3-[(1s,3R)-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl}-6-{[(3S)-3-methylpiperidin-1-yl]methyl}-4-(trifluoromethyl)-2,3-dihydro-1H-isoindol-1-one, ... (7 entities in total)
Functional Keywords	e3 ligase, cbl-b, inhibitor, sgc, ligase, ligase-ligase inhibitor complex, ligase/ligase inhibitor
Biological source	Homo sapiens (human)
Total number of polymer chains	1
Total formula weight	45979.17
Authors	Kimani, S.,Zeng, H.,Dong, A.,Li, Y.,Santhakumar, V.,Arrowsmith, C.H.,Edwards, A.M.,Halabelian, L.,Structural Genomics Consortium (SGC) (deposition date: 2023-03-03, release date: 2023-03-22, Last modification date: 2024-04-03)
Primary citation	Kimani, S.W.,Perveen, S.,Szewezyk, M.,Zeng, H.,Dong, A.,Li, F.,Ghiabi, P.,Li, Y.,Chau, I.,Arrowsmith, C.H.,Barsyte-Lovejoy, D.,Santhakumar, V.,Vedadi, M.,Halabelian, L. The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition. Commun Biol, 6:1272-1272, 2023 Cited by PubMed: 38104184 DOI: 10.1038/s42003-023-05655-8 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.81 Å)

Structure validation